Skip to main content
. 2017 Nov 10;8(61):104508–104524. doi: 10.18632/oncotarget.22356

Figure 8. SPARC was inversed with the expression of hsa-miR-29c-3p in CRC, as a direct target.

Figure 8

(A) Predicted SRCIN1 3′-UTR binding site for hsa-miR-29c-3p. (B) The relative luciferase activity of the reporter gene in transfected CRC cells. MC group is the 576 mimic control group.M. the hsa-miR-29c-3p mimic group. IC group is the inhibitor control group. I group is the hsa-miR-29c-3p inhibitor group. *P < 0.05.